Pregnolia raises €2.3M round
16 November 2023· Schlieren, Switzerland· health, women_health, medical_device, diagnostics, software_hardware, b2b
The investment is designated for the development and expansion of the Pregnolia device into a comprehensive diagnostic system, funding ongoing clinical studies, data processing, and formulating a roadmap for obtaining US Food and Drug Administration (FDA) approval for market entry in the US.
About Pregnolia
Stage
Series A
Headquarters
Schlieren, Switzerland
Founded
2016
Team Size
6–20
Sectors
healthwomen_healthmedical_devicediagnosticssoftware_hardwareb2b